Tandem Diabetes Care ( NASDAQ:TNDM – Get Free Report ) last released its quarterly earnings results on Wednesday, August 6th. The medical device company reported ($0.48) EPS for the quarter, missing the consensus estimate of ($0.40) by ($0.08). Tandem Diabetes Care had a negative return on equity of 65.40% and a negative net margin of 20.51%.The business had revenue of $240.68 million during the quarter, compared to analyst estimates of $238.39 million. During the same quarter last year, the firm posted ($0.47) EPS. The company's revenue was up 8.5% compared to the same quarter last year. As a group, sell-side analysts predict that Tandem Diabetes Care, Inc. will post -1.68 earnings per share for the current fiscal year.